glp 1 drugs and antidepressants Study finds GLP-1 receptor agonist use increases likelihood of antidepressant prescription GLP-1 receptor agonists | How
Description
Pratley, MD, co-chair of the FLOW trial, the Samuel E
Targher G, Tilg H, Byrne CD
[6] In 2023, it was the 63rd most commonly prescribed medication in the United States, with more than 10 million prescriptions
Abstract Background Polycystic ovary syndrome (PCOS) is a complex endocrine characterized by hyperandrogenism, hormonal imbalances, and metabolic disruptions, leading to reproductive complications and increased risk of cardiometabolic diseases
Those with medical need often struggle for access
This is non-negotiable
